Subscribe To
Conagra sales decline but beat the street
Conagra Brands Inc. CAG, +0.61% reported fiscal first quarter net income totaling $235.4 million, or 49 cents ...
October 7, 2021, 7:55 am
Conagra sales decline but beat the street
Conagra Brands Inc. CAG, +0.61% reported fiscal first quarter net income totaling $235.4 million, or 49 cents ...
October 7, 2021, 7:55 am
Conagra sales decline but beat the street
Conagra Brands Inc. CAG, +0.61% reported fiscal first quarter net income totaling $235.4 million, or 49 cents ...
October 7, 2021, 7:55 am
Tilray posts larger-than-expected loss
Tilray Inc. TLRY, -2.79% said Thursday its first quarter net loss widened to $34.6 million or 8 cents a...
October 7, 2021, 7:18 am
Tilray posts larger-than-expected loss
Tilray Inc. TLRY, -2.79% said Thursday its first quarter net loss widened to $34.6 million or 8 cents a...
October 7, 2021, 7:18 am
Tilray posts larger-than-expected loss
Tilray Inc. TLRY, -2.79% said Thursday its first quarter net loss widened to $34.6 million or 8 cents a...
October 7, 2021, 7:18 am
Blackstone minerals initiated by shaw and partners with a a$1.90 per share price target
Blackstone Minerals Ltd has been initiated by investment and wealth manager Shaw and Partners with a buy recommendation and a price target of A$1.90 p...
October 6, 2021, 10:37 pm
Blackstone minerals initiated by shaw and partners with a a$1.90 per share price target
Blackstone Minerals Ltd has been initiated by investment and wealth manager Shaw and Partners with a buy recommendation and a price target of A$1.90 p...
October 6, 2021, 10:37 pm
Blackstone minerals initiated by shaw and partners with a a$1.90 per share price target
Blackstone Minerals Ltd has been initiated by investment and wealth manager Shaw and Partners with a buy recommendation and a price target of A$1.90 p...
October 6, 2021, 10:37 pm
Gold futures finish higher as bond yields weaken
Gold futures finished with a modest gain on Wednesday, finding support from weakness in U.S. Treasury yields, even as the dollar strengthened. Decembe...
October 6, 2021, 1:36 pm
Gold futures finish higher as bond yields weaken
Gold futures finished with a modest gain on Wednesday, finding support from weakness in U.S. Treasury yields, even as the dollar strengthened. Decembe...
October 6, 2021, 1:36 pm
Gold futures finish higher as bond yields weaken
Gold futures finished with a modest gain on Wednesday, finding support from weakness in U.S. Treasury yields, even as the dollar strengthened. Decembe...
October 6, 2021, 1:36 pm
Cvs health announces quarterly dividend
WOONSOCKET, R.I., Oct. 5, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend o...
October 5, 2021, 4:36 pm
Cvs health announces quarterly dividend
WOONSOCKET, R.I., Oct. 5, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend o...
October 5, 2021, 4:36 pm
Cvs health announces quarterly dividend
WOONSOCKET, R.I., Oct. 5, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend o...
October 5, 2021, 4:36 pm
Cvs health announces quarterly dividend
WOONSOCKET, R.I., Oct. 5, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend o...
October 5, 2021, 4:36 pm
Cvs health announces quarterly dividend
WOONSOCKET, R.I., Oct. 5, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend o...
October 5, 2021, 4:36 pm
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am